Literature DB >> 2487531

A comparison of sotalol and procainamide in symptomatic ventricular tachycardia.

L J Jordaens1, F Colardyn, D L Clement.   

Abstract

UNLABELLED: The effects of oral sotalol were compared with 1000 and 1500 mg of procainamide in 23 patients with sustained ventricular tachycardia. The predictive value of an induction study after procainamide was assessed. The mean age of the study group was 62 +/- 12 years, and the mean ejection fraction was 32 +/- 16%. The cycle length (CL) of the induced tachycardia, the coupling interval (CI) of the first extrastimulus (in ms), and the number of noninducible (NI) patients are given in the table below. (table; see text) One patient developed torsades during the loading period of sotalol and is included in the number requiring cardioversion (DC). Important proarrhythmic effects (spontaneous occurrence of tachycardia) were seen twice after procainamide. Induction suppression by procainamide predicted success with sotalol (p = 0.0013).
CONCLUSION: Ventricular tachycardia seems to be less often inducible after oral sotalol than after procainamide. The success of procainamide during programmed electrical stimulation predicts the same for sotalol. If ventricular tachycardia remains inducible after oral sotalol, it is faster than after procainamide but slower than the baseline tachycardia. Both drugs slightly prolong refractoriness.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2487531     DOI: 10.1007/bf01883859

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  34 in total

1.  Is programmed stimulation of value in predicting the long-term success of antiarrhythmic therapy for ventricular tachycardias?

Authors:  S G Kim; S W Seiden; S D Felder; L E Waspe; J D Fisher
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

2.  Beta blockade during and after myocardial infarction: an overview of the randomized trials.

Authors:  S Yusuf; R Peto; J Lewis; R Collins; P Sleight
Journal:  Prog Cardiovasc Dis       Date:  1985 Mar-Apr       Impact factor: 8.194

3.  Large dose procainamide therapy for ventricular tachyarrhythmia.

Authors:  A M Greenspan; L N Horowitz; S R Spielman; M E Josephson
Journal:  Am J Cardiol       Date:  1980-09       Impact factor: 2.778

4.  The efficacy of amiodarone for ventricular arrhythmias cannot be predicted with clinical electrophysiological studies.

Authors:  H L Waxman
Journal:  Int J Cardiol       Date:  1983-04       Impact factor: 4.164

5.  Effect of procainamide, propranolol and verapamil on mechanism of tachycardia in patients with chronic recurrent ventricular tachycardia.

Authors:  H J Wellens; F W Bär; K I Lie; D R Düren; H J Dohmen
Journal:  Am J Cardiol       Date:  1977-10       Impact factor: 2.778

Review 6.  The automatic implantable cardioverter-defibrillator: an overview.

Authors:  M Mirowski
Journal:  J Am Coll Cardiol       Date:  1985-08       Impact factor: 24.094

7.  Electrophysiologic testing in assessment of therapy with sotalol for sustained ventricular tachycardia.

Authors:  J Senges; W Lengfelder; R Jauernig; E Czygan; J Brachmann; I Rizos; S Cobbe; W Kübler
Journal:  Circulation       Date:  1984-03       Impact factor: 29.690

8.  Reduction in sudden death and total mortality by antiarrhythmic therapy evaluated by electrophysiologic drug testing: criteria of efficacy in patients with sustained ventricular tachyarrhythmia.

Authors:  T J Waller; H R Kay; S R Spielman; S P Kutalek; A M Greenspan; L N Horowitz
Journal:  J Am Coll Cardiol       Date:  1987-07       Impact factor: 24.094

9.  Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone.

Authors:  B McGovern; H Garan; R F Malacoff; J P DiMarco; G Grant; T D Sellers; J N Ruskin
Journal:  Am J Cardiol       Date:  1984-06-01       Impact factor: 2.778

10.  Comparative electrophysiologic effects of intravenous and oral procainamide in patients with sustained ventricular arrhythmias.

Authors:  F E Marchlinski; A E Buxton; J A Vassallo; H L Waxman; D M Cassidy; J U Doherty; M E Josephson
Journal:  J Am Coll Cardiol       Date:  1984-12       Impact factor: 24.094

View more
  1 in total

Review 1.  Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.

Authors:  A Fitton; E M Sorkin
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.